Melodiol Global Health Ltd
ASX:ME1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Melodiol Global Health Ltd
ASX:ME1
|
AU |
|
Henkel AG & Co KGaA
XETRA:HEN
|
DE |
|
Jinhui Liquor Co Ltd
SSE:603919
|
CN |
|
C
|
Central Global Bhd
KLSE:CGB
|
MY |
|
X
|
Xinjiang LaChapelle Fashion Co Ltd
HKEX:6116
|
CN |
Balance Sheet
Balance Sheet Decomposition
Melodiol Global Health Ltd
Melodiol Global Health Ltd
Balance Sheet
Melodiol Global Health Ltd
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
3
|
12
|
6
|
3
|
6
|
7
|
1
|
1
|
|
| Cash Equivalents |
0
|
3
|
12
|
6
|
3
|
6
|
7
|
1
|
1
|
|
| Total Receivables |
0
|
1
|
1
|
1
|
2
|
1
|
1
|
5
|
3
|
|
| Accounts Receivables |
0
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
|
| Inventory |
0
|
0
|
0
|
0
|
2
|
1
|
1
|
6
|
2
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
4
|
15
|
8
|
7
|
8
|
10
|
12
|
6
|
|
| PP&E Net |
0
|
0
|
0
|
10
|
11
|
10
|
10
|
10
|
10
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
10
|
10
|
10
|
10
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
|
| Intangible Assets |
0
|
0
|
0
|
4
|
4
|
1
|
8
|
16
|
4
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
4
+2 118%
|
22
+473%
|
22
+3%
|
23
+2%
|
19
-16%
|
29
+53%
|
38
+30%
|
19
-50%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
1
|
1
|
3
|
2
|
1
|
0
|
4
|
22
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
3
|
3
|
3
|
0
|
0
|
9
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
|
| Total Current Liabilities |
0
|
1
|
1
|
6
|
5
|
5
|
2
|
16
|
23
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+308%
|
1
+8%
|
6
+898%
|
5
-12%
|
5
+9%
|
2
-71%
|
16
+906%
|
23
+47%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
5
|
35
|
38
|
47
|
72
|
110
|
128
|
150
|
|
| Retained Earnings |
0
|
2
|
14
|
22
|
29
|
58
|
84
|
109
|
158
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
4
|
|
| Total Equity |
0
N/A
|
3
+10 700%
|
21
+549%
|
17
-21%
|
18
+6%
|
14
-23%
|
28
+103%
|
22
-20%
|
4
N/A
|
|
| Total Liabilities & Equity |
0
N/A
|
4
+2 118%
|
22
+473%
|
22
+3%
|
23
+2%
|
19
-16%
|
29
+53%
|
38
+30%
|
19
-50%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
58
|
58
|
110
|
124
|
174
|
902
|
1 226
|
1 836
|
8
|
|